Evidence map›Paper›PMID 41566130›Full record

ArticleAnnals of surgical oncology2026

Inframesocolic Artery-First Approach with SMA Divestment to Confirm Resectability in Minimally Invasive Modified Appleby Procedure.

Nuria Blanco, Daniel Aliseda, Gabriel Zozaya, Pablo Martí-Cruchaga, Juan José Gascón, Lucas Sabatella, Alberto Benito, Fernando Rotellar

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nuria BlancoDepartment of General Surgery, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain. nblancoasen@unav.es.ORCID http://orcid.org/0009-0009-1495-2321
Daniel AlisedaDepartment of General Surgery, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Gabriel ZozayaDepartment of General Surgery, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Pablo Martí-CruchagaDepartment of General Surgery, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Juan José GascónDepartment of General Surgery, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Lucas SabatellaDepartment of General Surgery, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Alberto BenitoDepartment of General Surgery, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Fernando RotellarDepartment of General Surgery, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUsually conducted through open access, minimally invasive (MIS) distal pancreatectomy with celiac axis resection (DP-CAR) is uncommon and technically demanding.

resultsThe surgery was achieved with no requirement for conversion to open surgery. The patient's postoperative course was uneventful, with discharge on day seven and confirmed R0 resection on pathology. At eight months follow-up, she remains recurrence-free and asymptomatic.

conclusionsThe ligament of Treitz approach facilitates the assessment of tumor resectability and dissection of the SMA adventitia before undertaking irreversible surgical steps.

Indexed as

Carcinoma, Pancreatic DuctalCeliac ArteryLaparoscopyMesenteric Artery, SuperiorMinimally Invasive Surgical ProceduresPancreatectomyPancreatic NeoplasmsAgedAntineoplastic Combined Chemotherapy ProtocolsFemaleHumansPrognosis

Identifiers

PMID41566130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.